Suppr超能文献

发现一种依赖 DCAF11 的含氰基丙烯酰胺的 BET 蛋白共价降解剂。

Discovery of a DCAF11-dependent cyanoacrylamide-containing covalent degrader of BET-proteins.

机构信息

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

出版信息

Bioorg Med Chem Lett. 2024 Jul 15;107:129779. doi: 10.1016/j.bmcl.2024.129779. Epub 2024 May 9.

Abstract

Targeted protein degradation is mediated by small molecules that induce or stabilize protein-protein interactions between targets and the ubiquitin-proteasome machinery. Currently, there remains a need to expand the repertoire of viable E3 ligases available for hijacking. Notably, covalent chemistry has been employed to engage a handful of E3 ligases, including DCAF11. Here, we disclose a covalent PROTAC that enables DCAF11-dependent degradation, featuring a cyanoacrylamide warhead. Our findings underscore DCAF11 as an interesting candidate with a capacity to accommodate diverse electrophilic chemistries compatible with targeted protein degradation.

摘要

靶向蛋白降解是由小分子介导的,这些小分子诱导或稳定靶标与泛素-蛋白酶体机器之间的蛋白质-蛋白质相互作用。目前,仍然需要扩大可用于劫持的可行 E3 连接酶的范围。值得注意的是,已经采用了共价化学来结合少数几种 E3 连接酶,包括 DCAF11。在这里,我们披露了一种能够实现 DCAF11 依赖性降解的共价 PROTAC,其特征是氰基丙烯酰胺弹头。我们的研究结果强调了 DCAF11 作为一个有趣的候选者,具有容纳与靶向蛋白降解兼容的各种亲电化学的能力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验